original ) (raw )Effect of antiretroviral treatment on the risk of tuberculosis during South Africa's programme expansion
Venessa Timmerman
PubMed, 2015
View PDFchevron_right
The impact of HIV and ART on recurrent tuberculosis in a sub-Saharan setting
Sebastian Mboma
AIDS, 2012
View PDFchevron_right
The effect of antiretroviral treatment on HIV associated tuberculosis incidence and outcomes in the Free State Province, South Africa
Venessa Timmerman
2013
View PDFchevron_right
Tuberculosis Incidence Rates during 8 Years of Follow-Up of an Antiretroviral Treatment Cohort in South Africa: Comparison with Rates in the Community
Robin Wood
PLoS ONE, 2012
View PDFchevron_right
Active Tuberculosis Is Associated with Worse Clinical Outcomes in HIV-Infected African Patients on Antiretroviral Therapy
Lameck Diero , Sylvester Kimaiyo , Beverly Musick
PLoS ONE, 2013
View PDFchevron_right
Loss to Follow-Up and Mortality Among HIV-Infected People Co-Infected With TB at ART Initiation in Durban, South Africa
ingrid bassett
View PDFchevron_right
Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it? [Unresolved issues]
Robin Wood
The International Journal of Tuberculosis and Lung Disease, 2011
View PDFchevron_right
Impact of ART on TB Case Fatality Stratified by CD4 Count for HIV-Positive TB Patients in Cape Town, South Africa (2009–2011)
Robin Wood
JAIDS Journal of Acquired Immune Deficiency Syndromes, 2014
View PDFchevron_right
Tuberculosis Incidence and Mortality Rates Among People Living with HIV Receiving Antiretroviral Therapy at the Buea Regional Hospital: A Seven Year Retrospective Study
Anna Longdoh Njunda
International Journal of HIV/AIDS Prevention, Education and Behavioural Science, 2019
View PDFchevron_right
Prevalent and Incident Tuberculosis Are Independent Risk Factors for Mortality among Patients Accessing Antiretroviral Therapy in South Africa
Robin Wood
PLoS ONE, 2013
View PDFchevron_right
Incident Tuberculosis during Antiretroviral Therapy Contributes to Suboptimal Immune Reconstitution in a Large Urban HIV Clinic in Sub-Saharan Africa
Sabine Hermans
PLOS One, 2010
View PDFchevron_right
ACTG A5221 STRIDE: An international randomized trial of immediate vs early antiretroviral therapy (ART) in HIV+ patients treated for tuberculosis
Johnstone Kumwenda
View PDFchevron_right
Temporal Association Between Incident Tuberculosis and Poor Virological Outcomes in a South African Antiretroviral Treatment Service
Robin Wood
JAIDS Journal of Acquired Immune Deficiency Syndromes, 2013
View PDFchevron_right
Antiretroviral Treatment-Associated Tuberculosis in a Prospective Cohort of HIV-Infected Patients Starting ART
Luc Kestens
Clinical and Developmental Immunology, 2011
View PDFchevron_right
Incidence of Tuberculosis amongst HIV positive individuals initiating antiretroviral treatment at higher CD4 counts in the HPTN 071 (PopART) trial in South Africa
Emmanuel Okoli
Journal of acquired immune deficiency syndromes (1999), 2017
View PDFchevron_right
Does Early ART Initiation is Better than Later ART Initiation in TB/HIV Co-infected Patients? A Retrospective Cohort Study
Hiluf Hindeya
2020
View PDFchevron_right
Antiretroviral Program Associated with Reduction in Untreated Prevalent Tuberculosis in a South African Township
Robin Wood
American Journal of Respiratory and Critical Care Medicine, 2010
View PDFchevron_right
Tuberculosis in Patients Receiving Antiretroviral Treatment: Incidence, Risk Factors, and Prevention Strategies
Daniel Westreich
JAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
View PDFchevron_right
Tuberculosis preventive treatment opportunities at antiretroviral therapy initiation and follow-up visits
Tefera Agizew
Public Health Action, 2020
View PDFchevron_right
Active tuberculosis disease among people living wi with HIV on ART who completed tuberculosis preventive therapy at three public hospitals in Uganda
Shallon Atuhaire
PLOS ONE | https://doi.org/10.1371/journal.pone.0313284 November 11, 2024, 2024
View PDFchevron_right
ART uptake, its timing and relation to anti-tuberculosis treatment outcomes among HIV-infected TB patients
T. Murimwa
Public Health Action, 2012
View PDFchevron_right
Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy
Alimuddin Zumla
International Journal of Infectious Diseases, 2017
View PDFchevron_right
High Rates of Virological Suppression in a Cohort of Human Immunodeficiency Virus- Positive Adults Receiving Antiretroviral Therapy in Ethiopian Health Centers Irrespective of Concomitant Tuberculosis
Taye Balcha
View PDFchevron_right
Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial
Henry Luwaga , Wanze Kohi , Grace Nyakoojo , oliver Ezechi , Philip Onyebujoh , Edford Sinkala
The Lancet Infectious Diseases, 2014
View PDFchevron_right
Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial
Eleni Aklillu
PLOS ONE, 2015
View PDFchevron_right
The effect of incident tuberculosis on immunological response of HIV patients on highly active anti-retroviral therapy at the university of Gondar hospital, northwest Ethiopia: a retrospective follow-up study
Gebeyaw Getnet , Gashaw Yitayew
BMC Infectious Diseases, 2014
View PDFchevron_right